Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive form of blood cancer that primarily affects older adults. It is characterized by the proliferation of precursors of ...

Researchers at MedUni Vienna have developed a combination therapy using systemic interferon-I and topical imiquimod.

Airway epithelial cells prime plasmacytoid dendritic cells to respond to pathogens via secretion of growth factors. Mucosal Immunology 12 (1), 77-84 (2019). (*equal first author). Impact 7.2 ...

A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.